Family Medicine Doctors in Molalla, OR Accepting Medicare
3 Family Medicine doctors found. Showing 1 - 3
 Ray E Smucker, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 110 Center Ave, Molalla, OR 97038 Phone: 503-829-2273 Fax: 503-829-2291 |
Arturo Salazar, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 110 Center Ave, Molalla, OR 97038 Phone: 503-829-2273 |
Mich Andrew Gehrig Jr., DO Family Medicine Medicare: Medicare Enrolled Practice Location: 110 Center Ave, Molalla, OR 97038 Phone: 503-405-3777 |
News Archive
Tacere Therapeutics submits TT-034 clinical trial application to Recombinant DNA Advisory Committee
RNAi-based therapeutics company Benitec Biopharma Limited today announced that the company's wholly owned US subsidiary, Tacere Therapeutics Inc., has submitted an application to the US National Institutes of Health's Recombinant DNA Advisory Committee.
Patient recruitment complete for immatics IMA901 Phase 3 trial for renal cell carcinoma
immatics biotechnologies GmbH, a biopharmaceutical company developing rationally designed therapeutic vaccines that are active against cancer, announced today that it has completed patient recruitment into the pivotal phase 3 trial evaluating its lead cancer vaccine IMA901 for renal cell carcinoma (RCC). The trial has completed patient inclusion and it is expected that around 345 patients will be randomized across 10 countries in the US and Europe.
FDA approves Enablex for the treatment of overactive bladder
Novartis Pharmaceuticals Corporation today announced that the U.S. Food and Drug Administration (FDA) has approved Enablex® (darifenacin) extended-release tablets (7.5mg and 15mg) for the treatment of overactive bladder (OAB) with symptoms of urge urinary incontinence, urgency and frequency.
First clear evidence that olfaction is uniquely a "dual" sense
In the August 18, 2005, issue of Neuron, researchers report that the smell of chocolate activated different brain regions according to whether the odor was introduced into the olfactory system through the mouth or through the nose.
Orexigen Therapeutics, Valeant Pharmaceuticals sign distribution agreement for Mysimba
Orexigen Therapeutics, Inc. today announced Valeant Pharmaceuticals International, Inc. will commercialize Mysimba (naltrexone HCl / bupropion HCl prolonged release) in Central and Eastern Europe.
› Verified 9 days ago